跳至主要内容
临床试验/ITMCTR2022000072
ITMCTR2022000072尚未招募1 期

A pragmatic randomized controlled trial of the usefulness of Chinese medicine in the treatment of pulmonary nodules

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • (1) Age 18-80 years.
  • (2) Karnofsky score =90.
  • (3) Less than 15 mm pure ground glass/solid component less than 15 mm partially solid pulmonary nodules.
  • (4) Basic normal function of heart, liver, kidney and hematopoietic system.
  • (5) Voluntary participation in this study and signed informed consent.

排除标准

  • (1) Total number of pulmonary nodules = 10.
  • (2) Patients considered to have pulmonary nodular disease, tuberculosis, intrapulmonary lymph nodes, malignancy, sclerosing angioma, sarcoidosis, or lymphoma.
  • (3) Current symptoms suggestive of lung cancer: unexplained weight loss of more than 6.5 kg in the past 12 months, or unexplained hemoptysis.
  • (4) Patients undergoing treatment with targeted, immune, chemotherapy, radiotherapy, etc.
  • (5) Patients who are receiving anti-inflammatory therapy or within 1 month of the end of anti-inflammatory therapy.
  • (6) Patients whose imaging of non-first detected nodules suggests that the nodules are progressing or resorbing
  • (7) Patients who are children, pregnant women, psychiatric patients, and patients with tumors that have not undergone radical surgery.
  • (8) Patients who are taking other drugs or health food that have an effect on this trial.
  • (9) Those who are participating in other clinical trials.

研究者

相似试验